The Cost of Delayed Recovery: Connecting Rehabilitation to Business Value
What does another week of recovery mean for an injured worker, a workers’ compensation claim, and an employer? This webinar explores how recovery time connects wage replacement and rehabilitation spending with lost workdays, staffing pressures, and reduced productivity. Join Josh Rabinowitz, Co-Founder and CEO of Articulate Labs, and Demi Radeva, MSc, Founder and CEO of Akros Advisory, for a practical conversation about what buyers need to see before considering rehabilitation technology.
Josh brings firsthand experience building wearable rehabilitation devices and leading fundraising, business development, and partnerships, with support from nationally recognized healthtech accelerator programs. He will share how Articulate Labs is approaching rehabilitation between clinic visits through KneeStim, a wearable device designed to synchronize quadriceps stimulation with everyday movement and provide adherence and mobility data.
Demi brings a decade of experience across Medicaid, Medicare, and commercial health plans at UnitedHealthcare and Optum, alongside work helping more than 50 startups navigate funding, payer contracts, and sustainable go-to-market strategies. Together, they will connect the clinical rationale for recovery support with the evidence, economics, and workflow considerations that shape buyer decisions.
Why Attend
Understand how delayed recovery affects claim spending, lost workdays, and employer costs.
Explore barriers to consistent rehabilitation and the potential role of support between clinic visits.
Learn how to evaluate clinical evidence and economic models, including which assumptions need testing with a buyer’s own data.
Who Is This For
Workers’ compensation insurers, TPAs, claims leaders, and case managers evaluating rehabilitation approaches.
Employers, risk managers, and occupational health teams focused on recovery and return to work.
Healthtech founders and commercial leaders building a credible, buyer-relevant value proposition.
Choose Your Ticket
Free | Live Webinar Access
Join the live webinar and hear Josh and Demi’s discussion on the clinical, economic, and buyer considerations shaping rehabilitation technology adoption.
$27 | Webinar + Take-Home Toolkit
Get everything included with the free ticket, plus the full webinar recording, slide deck, and a practical take-home toolkit designed to help you apply the discussion to your own solution. The toolkit includes worksheets, frameworks, and exercises to help assess buyer needs, evaluate clinical and economic value, identify relevant evidence, and strengthen your solution’s value proposition.
All attendees will also receive the opportunity to book a discounted strategy session with Demi following the webinar.
KneeStim is investigational and not FDA cleared in the supplied materials. The discussion distinguishes potential value and modeled savings from demonstrated outcomes.